You have 9 free searches left this month | for more free features.

Factor IX

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hemophilia A With Inhibitors, Hemophilia B With Inhibitors Trial in Worldwide (Coagulation FVIIa (Recombinant))

Completed
  • Hemophilia A With Inhibitors
  • Hemophilia B With Inhibitors
  • Coagulation FVIIa (Recombinant)
  • Aurora, Colorado
  • +8 more
Feb 24, 2022

Severe Hemophilia B Trial in Worldwide (Factor IX (rFIXFc), rFIX)

Completed
  • Severe Hemophilia B
  • Factor IX (rFIXFc)
  • rFIX
  • Phoenix, Arizona
  • +50 more
Dec 16, 2020

Drawn From Central Venous Lines and Venipuncture

Terminated
  • Hemophilia A
  • +4 more
  • Peripheral Vein Blood draw
  • Kansas City, Missouri
    Children's Mercy Hospital
Jan 5, 2021

Fc factOrs and Real-World hemophiliA Patient-ReporteD Outcomes

Terminated
  • Hemophilia A
  • Hemophilia B
  • rFVIIIFc
  • +3 more
  • Los Angeles, California
  • +1 more
Dec 16, 2020

Dosage and PD Study of Eftrenonacog-alfa

Unknown status
  • Severe Haemophilia B
  • Non interventional study
  • Paris, France
    Service d'hématologie biologique - Hôpital Cochin
Oct 15, 2020

Male, Hemophilia A With Inhibitor, Hemophilia B With Inhibitor Trial in China (SS109)

Not yet recruiting
  • Male
  • +3 more
  • Hefei, China
  • +8 more
Aug 24, 2023

Service - Hemophilia: Sources of Variability

Enrolling by invitation
  • Hemophilia A
  • Hemophilia B
  • Variability in individual PK
  • Hamilton, Ontario, Canada
    McMaster University
Sep 17, 2021

Hemophilia B Trial in Worldwide (Recombinant factor IX)

Completed
  • Hemophilia B
  • Recombinant factor IX
  • Rosario, Argentina
  • +13 more
Apr 30, 2021

(Usage Results Study) of RIXUBIS in Adult and Pediatric

Completed
  • Hemophilia B
  • RIXUBIS
  • Daegu, Korea, Republic of
  • +4 more
Apr 30, 2021

Hemophilia B Trial in Worldwide (Factor IX Concentrate (purified, virus-inactivated))

Completed
  • Hemophilia B
  • Factor IX Concentrate (purified, virus-inactivated)
  • Corrientes, Argentina
  • +17 more
Apr 21, 2021

ATHN 2: Factor Switching Study

Completed
  • Hemophilia
  • Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013
  • Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013
  • San Diego, California
  • +26 more
Dec 7, 2021

Hemophilia B Trial in Worldwide (PF-06838435 (formerly SPK-9001))

Recruiting
  • Hemophilia B
  • PF-06838435 (formerly SPK-9001)
  • Sacramento, California
  • +24 more
Feb 2, 2023

Prothrombin Complex Factor Deficiency Trial in Austria, Hungary (Prothrombin complex concentrate (coagulation factors IX, II,

Completed
  • Prothrombin Complex Factor Deficiency
  • Prothrombin complex concentrate (coagulation factors IX, II, VII and X in combination)
  • Feldkirch, Austria
  • +5 more
Apr 30, 2021

Hemophilia B Trial in United States (rFIXFc)

Completed
  • Hemophilia B
  • Chicago, Illinois
  • +5 more
Dec 16, 2020

Hemophilia B Trial in Worldwide (BAX326)

Completed
  • Hemophilia B
  • BAX326
  • New Delhi, India
  • +10 more
Apr 30, 2021

Hemophilia B Trial in United Kingdom, United States (Gene Transfer, scAAV2/8-LP1-hFIXco)

Active, not recruiting
  • Hemophilia B
  • Stanford, California
  • +7 more
Nov 17, 2022

Patients With End Stage Liver Disease

Not yet recruiting
  • Liver Cirrhosis
  • +6 more
    • Palo Alto, California
      Stanford Hospital
    Aug 23, 2023

    Hemophilia B Trial (BBM-H901)

    Not yet recruiting
    • Hemophilia B
    • (no location specified)
    Feb 6, 2023

    (SPACE) in Hemophilia Patients Currently Treated With ADVATE or

    Completed
    • Hemophilia A
    • Hemophilia B
    • ADVATE (Antihemophilic Factor [Recombinant])
    • RIXUBIS (Coagulation Factor IX [Recombinant])
    • Los Angeles, California
    • +16 more
    Mar 16, 2021

    LTFU for Gene Transfer Subjects With Hemophilia B

    Completed
    • Hemophilia B
      • Philadelphia, Pennsylvania
      • +1 more
      May 14, 2020

      Hemophilia B Trial in Worldwide (BAX 326 (Recombinant factor IX))

      Completed
      • Hemophilia B
      • BAX 326 (Recombinant factor IX)
      • Rosario, Argentina
      • +41 more
      Apr 30, 2021

      Liver Biopsy Following Gene Therapy For Hemophilia

      Not yet recruiting
      • Hemophilia A
      • Hemophilia B
      • Liver Biopsy
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Jun 27, 2023

      Severe Hemophilia B Trial in Worldwide (rFIXFc)

      Completed
      • Severe Hemophilia B
      • rFIXFc
      • Phoenix, Arizona
      • +48 more
      Dec 16, 2020

      Joint Health Study

      Completed
      • Hemophilia B
        • Los Angeles, California
        • +4 more
        Jun 17, 2022

        Hemophilia A, Hemophilia B Trial in Korea, Republic of, South Africa, Taiwan (marstacimab)

        Recruiting
        • Hemophilia A
        • Hemophilia B
        • Seoul, Seoul-teukbyeolsi [seoul], Korea, Republic of
        • +3 more
        Jan 18, 2023